We are pleased to announce the commissioning of our first medical cyclotron facility, an advanced 18 MeV Cyclotron installed in Vizag, Andhra Pradesh, in January 2025. This milestone marks a major step forward in strengthening our PET radiopharmaceutical production capabilities.

This modern cyclotron is engineered to deliver exceptional performance and currently holds the highest production capacity to date—capable of generating up to 30 Ci of F-18 in a single run.

Equipped with state-of-the-art production modules, high-efficiency target systems, and an upgraded QC infrastructure, the facility enables reliable manufacturing of F-18/FDG and a broad range of other 18F-based radiopharmaceuticals. The enhanced capacity ensures improved availability, consistency, and timely distribution for nuclear medicine centers across the region.

With this milestone, we further reinforce our commitment to supplying high-quality, GMP-compliant PET radiopharmaceuticals and supporting the evolving needs of the nuclear medicine community.

With this milestone, we further reinforce our commitment to supplying high-quality, GMP-compliant PET radiopharmaceuticals and supporting the evolving needs of the nuclear medicine community.